Trial Summary
What is the purpose of this trial?The purpose of this study is to study the use of a counterbalancing system of glucose and insulin infusion with frequent blood glucose monitoring and combined adaptive algorithm can produce tight glycemic control without hypoglycemia; study to develop a closed loop for use in intensive care units and surgery
Eligibility Criteria
This trial is for adults aged 21-85 with Type 1 or Type 2 diabetes, currently on insulin therapy, and have high blood sugar levels (>150 mg/dl) at the time of study. Their A1c levels should be between 7-9.9%. People who are pregnant, using corticosteroids, or have kidney/liver diseases, electrolyte imbalances, anemia or poor veins for drips cannot join.Inclusion Criteria
I am 21-85 years old with diabetes on insulin and my A1c is between 7-9.9%.
Exclusion Criteria
I have difficulty with IV insertions.
I have anemia.
Treatment Details
The study tests a system that balances glucose and insulin delivered directly into the bloodstream while frequently checking blood sugar levels. The goal is to maintain stable blood sugar without causing low blood sugar in patients in intensive care units or during surgery.
1Treatment groups
Experimental Treatment
Group I: insulin and glucose infusionExperimental Treatment1 Intervention
trial of experimental technique in outpatient setting; the group under study will be comprised of type 1 and type 2 diabetic individuals ; they will have automated treatment using algorithm which regulates balancing infusions of glucose and/or insulin intravenously without manual intervention; blood glucose target of 80-180 mg/dl will be guide for the automated system
Find a clinic near you
Research locations nearbySelect from list below to view details:
3113 Lawton RoadOrlando, FL
Loading ...
Who is running the clinical trial?
Admetsys CorporationLead Sponsor